Category Archives: Biotech Letter

The Grumpy Husband’s Guide To Getting Rich

I was having lunch with a buddy in Palo Alto last week when he mentioned that his wife’s doctor just prescribed her Ozempic. “Cost me eight hundred bucks for a month’s supply,” he grumbled, stabbing his salad. That’s when it hit me. We’re living through one of those rare moments when an entire industry gets […]

Built For Droughts

Let me tell you about my neighbor’s irrigation system. Five years ago, he spent a small fortune installing drip lines throughout his property. While everyone was comparing rose bushes and lawn ornaments, he was investing in a system that would never make the front page of the HOA newsletter but would save him a fortune. […]

From 365 to 2

Did you know that back in 1928, Alexander Fleming discovered penicillin purely by accident when he forgot to clean up his lab before going on vacation? Sometimes the most revolutionary medical breakthroughs happen when you least expect them. Fast forward to today, and Gilead Sciences (GILD) just pulled off something that might not be accidental, […]

When Good Earnings Can’t Hide The Ugly Truth

You know that feeling when your favorite restaurant starts serving smaller portions but jacks up the price? That’s Biogen (BIIB) right now. Sure, they beat Q2 earnings estimates like a drum, pulling in $2.65 billion in revenue against a $2.32 billion consensus, but scratch beneath that shiny surface and you’ll find the same old story […]